scispace - formally typeset
E

Edward D. Huey

Researcher at Columbia University

Publications -  137
Citations -  4188

Edward D. Huey is an academic researcher from Columbia University. The author has contributed to research in topics: Frontotemporal dementia & Dementia. The author has an hindex of 27, co-authored 113 publications receiving 2930 citations. Previous affiliations of Edward D. Huey include Columbia University Medical Center & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Frontotemporal dementia and its subtypes: a genome-wide association study

Raffaele Ferrari, +181 more
- 01 Jul 2014 - 
TL;DR: The findings suggest that immune system processes (link to 6p21.3) and possibly lysosomal and autophagy pathways ( link to 11q14) are potentially involved in FTD.
Journal ArticleDOI

A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia.

TL;DR: Studies of neurotransmitter deficiencies in frontotemporal dementia (FTD) can be helpful in developing treatments, and larger, well-controlled treatment studies are required to reach more definitive conclusions about treatment efficacy.
Journal ArticleDOI

FTD and ALS: a tale of two diseases.

TL;DR: A better understanding of the clinical, pathological and genetic features characterizing FTD and ALS will shed light into overlaps among these two disorders and the underpinning mechanisms that contribute to the onset and development.
Journal ArticleDOI

Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.

Katrina M. Moore, +177 more
- 01 Feb 2020 - 
TL;DR: An international study of age at symptom onset, age at death, and disease duration in individuals with mutations in GRN, MAPT, and C9orf72 to investigate the extent to which variability in age at onset and at death could be accounted for by family membership and the specific mutation carried.
Journal ArticleDOI

Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy

TL;DR: A genome-wide association study (GWAS) in CBD cases (n=152) and 3,311 controls, and 67 CBD cases and 439 controls in a replication stage was conducted in this article.